MR Imaging−Based Localized Intra-Arterial Thrombolysis Assisted by Mechanical Clot Disruption for Acute Ischemic Stroke due to Middle Cerebral Artery Occlusion

References

1. 1.↵
   The IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 2007;38:2127–35.Epub 2007 May 24

   Abstract/FREE Full Text
2. 2.↵
   1. Barnwell SL,
   2. Clark WM,
   3. Nguyen TT,
   4. et al

   . Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817–22

   Abstract/FREE Full Text
3. 3.↵
   1. Nakano S,
   2. Yokogami K,
   3. Ohta H,
   4. et al

   . Direct percutaneous transluminal angioplasty for acute middle cerebral artery occlusion. AJNR Am J Neuroradiol 1998;19:767–72

   Abstract
4. 4.↵
   1. Ueda T,
   2. Sakaki S,
   3. Nochide I,
   4. et al

   . Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998;29:2568–74

   Abstract/FREE Full Text
5. 5.↵
   1. Yoneyama T,
   2. Nakano S,
   3. Kawano H,
   4. et al

   . Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. AJNR Am J Neuroradiol 2002;23:277–81

   Abstract/FREE Full Text
6. 6.↵
   1. Qureshi AI,
   2. Siddiqui AM,
   3. Suri MF,
   4. et al

   . Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319–29

   PubMedWeb of Science
7. 7.↵
   1. Sorimachi T,
   2. Fujii Y,
   3. Tsuchiya N,
   4. et al

   . Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol 2004;25:1391–402

   Abstract/FREE Full Text
8. 8.↵
   1. Noser EA,
   2. Shaltoni HM,
   3. Hall CE,
   4. et al

   . Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?Stroke 2005;36:292–96

   Abstract/FREE Full Text
9. 9.↵
   1. Ikushima I,
   2. Ohta H,
   3. Hirai T,
   4. et al

   . Balloon catheter disruption of middle cerebral artery thrombus in conjunction with thrombolysis for the treatment of acute middle cerebral artery embolism. AJNR Am J Neuroradiol 2007;28:513–17

   Abstract/FREE Full Text
10. 10.↵
    1. Smith WS,
    2. Sung G,
    3. Saver J,
    4. et al.,
    5. for the Multi MERCI Investigators

    . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12

    Abstract/FREE Full Text
11. 11.↵
    1. Higashida RT,
    2. Furlan AJ,
    3. for the Technology Assessment Committees of the American Society of Interventional and Therapeutic Neuroradiology and the Society of Interventional Radiology

    . Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–37

    Abstract/FREE Full Text
12. 12.↵
    1. Barber PA,
    2. Demchuk AM,
    3. Zhang J,
    4. et al.,
    5. for the ASPECTS Study Group

    . Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670–74

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Hill MD,
    2. Rowley HA,
    3. Adler F,
    4. et al.,
    5. for the PROACT-II Investigators

    . Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925–31

    Abstract/FREE Full Text
14. 14.↵
    1. Furlan A,
    2. Higashida R,
    3. Wechsler L,
    4. et al.,
    5. for the PROACT Investigators

    . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. JAMA 1999;282:2003–11

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Ogawa A,
    2. Mori E,
    3. Minematsu K,
    4. et al.,
    5. for the MELT Japan Study Group

    . Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633–39

    Abstract/FREE Full Text
16. 16.↵
    1. Yamaguchi T,
    2. Mori E,
    3. Minematsu K,
    4. et al.,
    5. for the Japan Alteplase Clinical Trial (J-ACT) Group

    . Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan alteplase clinical trial (J-ACT). Stroke 2006;37:1810–15

    Abstract/FREE Full Text
17. 17.↵
    1. Khatri P,
    2. Wechsler LR,
    3. Broderick JP

    . Intracranial hemorrhage associated with revascularization therapies. Stroke 2007;38:431–40

    Abstract/FREE Full Text
18. 18.↵
    1. Ezura M,
    2. Takahashi A,
    3. Shimizu H,
    4. et al

    . Diffusion-weighted MRI and selection of patients for fibrinolytic therapy of acute cerebral ischaemia. Neuroradiology 2000;42:379–83

    CrossRefPubMed
19. 19.↵
    1. Nesbit GM,
    2. Luh G,
    3. Tien R,
    4. et al

    . New and future endovascular treatment strategies for acute ischemic stroke. J Vasc Interv Radiol 2004;15 (1 pt 2):S103–10

    CrossRefPubMed
20. 20.↵
    1. Gönner F,
    2. Remonda L,
    3. Mattle H,
    4. et al

    . Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998;29:1894–900

    Abstract/FREE Full Text
21. 21.↵
    1. Ueda T,
    2. Sakaki S,
    3. Kumon Y,
    4. et al

    . Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2360–65

    Abstract/FREE Full Text
22. 22.↵
    1. Kimura K,
    2. Iguchi Y,
    3. Shibazaki K,
    4. et al

    . Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke. Stroke 2008;39:2388–91

    Abstract/FREE Full Text